Unlearn

Unlearn utilizes AI to create digital twins of clinical trial participants, enhancing decision-making within clinical development. The platform streamlines the complex process of designing and executing clinical trials, enabling teams to leverage integrated evidence and data models. By using digital twins, Unlearn allows for more confident commitment to trial decisions, reducing trial size and accelerating timelines.

Key functionalities of Unlearn include trial planning and simulations, literature scouting, anomaly detection in clinical data, and analyses using digital twins. These features help trial teams not only to plan effectively but also to monitor and analyze trials for more informed decision-making. The AI-driven platform has shown real-world results, including significant reductions in control arm sizes and enrollment times.

Unlearn serves various therapeutic areas, including neuroscience and immunology, and collaborates with leading biopharma companies to implement its solutions. By facilitating smarter clinical trial designs, Unlearn aims to propel medical advancements and improve patient outcomes.